DOSE AND/OR VOLUME REDUCTION USING CONSOLIDATION VOLUME RADIATION THERAPY (CVRT) LOWERS DOSE TO HEART AND LUNGS IN EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH BULKY DISEASE. (June 2017) - Yang, J.C.; Kumar, A.; Chapman, K.L.; Burleson, S.; Huang, C.; Constine, L.S.; Hoppe, R.T.; Dandapani, S.; Straus, D.J.; Moskowitz, C.H.; Yahalom, J.